China Meheco Group Co., Ltd. (SHA: 600056)

Market Cap	19.61B
Revenue (ttm)	35.13B
Net Income (ttm)	901.08M
Shares Out	1.50B
EPS (ttm)	0.60
PE Ratio	21.77
Forward PE	n/a
Dividend	0.21 (1.76%)
Ex-Dividend Date	Sep 27, 2024

Volume	74,247,240
Open	11.89
Previous Close	11.92
Day's Range	11.84 - 13.11
52-Week Range	9.47 - 13.11
Beta	0.12
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2024

About China Meheco Group

China Meheco Group Co., Ltd. engages in the pharmaceutical business in China and internationally. The company exports and imports natural medicines, pharmaceutical chemicals, medical equipment, and health products; produces and distributes pharmaceutical and health care products; and operates retail chain pharmacies. Its products include bulk pharmaceutical chemicals antibiotic fermentation and chemical synthesis tablets, injections, capsules, etc.; antibiotics; medicines for the treatment of cardio-cerebrovascular diseases, chronic diseases, a...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1984
• Employees: 8,389
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600056

Financial Performance

In 2023, China Meheco Group's revenue was 38.82 billion, an increase of 3.28% compared to the previous year's 37.59 billion. Earnings were 1.05 billion, an increase of 42.47%.